share_log

HC Wainwright & Co. Reiterates Buy on Onconova Therapeutics, Maintains $11 Price Target

Benzinga ·  Jun 6, 2023 06:10

HC Wainwright & Co. analyst Joseph Pantginis reiterates Onconova Therapeutics (NASDAQ:ONTX) with a Buy and maintains $11 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment